Abazid Rami M, Ewid Mohammed, Sherif Hossam, Smettei Osama A, Salim Khan Abdul, Altorbag Abdullah A, Alharbi Mohammad F, Aljaber Abdulrahman N, Alharbi Suliman M, Altorbak Nora A, Altorbak Sarah A, Almeman Ahmad
Department of Nuclear Medicine, London Health Sciences Centre, London, Canada, Department of Cardiac Imaging, Prince Sultan Cardiac Center Qassim PSCCQ, Buraydah, El Qassim, Saudi Arabia.
Faculty of Medicine, Suliman Al Rajhi Colleges, Buraydah, El Qassim, Saudi Arabia, Internal Medicine Department, Faculty of Medicine, Cairo University, Egypt.
Avicenna J Med. 2019 Oct 3;9(4):148-153. doi: 10.4103/ajm.AJM_69_19. eCollection 2019 Oct-Dec.
Driving capability can be significantly affected by different heath disorders; cardiovascular diseases (CVDs) should be considered when assessing patients for medical fitness to drive (MFTD). The aim of this study was to evaluate the awareness of Saudi patients about driving recommendations and to assess the incidence of motor vehicle accidents (MVAs) among cardiac patients.
We conducted a cross-sectional survey-based study. Male patients diagnosed with CVDs and who were visiting outpatient departments were invited to complete a questionnaire regarding their awareness of driving recommendations. Patients' demographics, clinical diagnosis, echocardiography parameters, and time-to-CVD diagnosis were all obtained from the patients' medical records. Women were excluded because it was illegal for women to drive in Saudi Arabia during the study period.
In total, 800 men were included, with a mean age of 54 ± 12 years. Driving counseling had been provided to 241 participants (30%). Of these, 207 (25%) were advised not to drive for a period of between one week and six months. Five percent of the patients had a history of MVAs during the follow-up period of 6.2 ± 4 years. We found that the presence of a dyspnea ≥2, according to the New York Heart Association (NYHA), and a history of loss of consciousness (syncope/pre-syncope) were significantly associated with accidents (46% vs. 20%, < 0.0001 and 41% vs. 10%, < 0.0001, respectively).
Patient-physician discussion about MFTD was only performed with 30% of the patients with CVDs in Saudi Arabia. Dyspnea NYHA class ≥2 or a prior history of syncope were significantly associated with the incidence of MVAs.
不同健康问题会显著影响驾驶能力;在评估患者的医学驾驶适宜性(MFTD)时应考虑心血管疾病(CVD)。本研究旨在评估沙特患者对驾驶建议的知晓情况,并评估心脏病患者机动车事故(MVA)的发生率。
我们开展了一项基于横断面调查的研究。邀请诊断患有CVD且前来门诊就诊的男性患者填写一份关于他们对驾驶建议知晓情况的问卷。患者的人口统计学信息、临床诊断、超声心动图参数以及CVD诊断时间均从患者病历中获取。女性被排除,因为在研究期间沙特女性驾车是违法的。
共纳入800名男性,平均年龄为54±12岁。241名参与者(30%)接受了驾驶咨询。其中,207名(25%)被建议在1周-6个月内不要驾驶。在6.2±4年的随访期内,5%的患者有MVA病史。我们发现,根据纽约心脏协会(NYHA)标准,呼吸困难≥2级以及有意识丧失(晕厥/先兆晕厥)病史与事故显著相关(分别为46%对20%,<0.0001;41%对10%,<0.0001)。
在沙特阿拉伯,仅30%的CVD患者与医生讨论了MFTD。NYHA分级≥2级的呼吸困难或既往晕厥病史与MVA发生率显著相关。